Salta alla navigazione principale Salta alla ricerca Salta al contenuto principale

How to identify patients who are less likely to have metachronous neoplasms after a colon cancer: A predictive model

  • L. Frazzoni
  • , Lucrezia Laterza
  • , A. Mussetto
  • , R. M. Zagari
  • , C. Trovato
  • , Bellis M. De
  • , S. Paggi
  • , S. Piccirelli
  • , L. Ricciardiello
  • , P. Cesaro
  • , Cristiano Spada
  • , Piaz G. Dal
  • , Marca M. La
  • , F. Fabbian
  • , L. Petrella
  • , V. Smania
  • , P. Marone
  • , F. Tatangelo
  • , F. Bazzoli
  • , F. Radaelli
  • A. Repici, C. Hassan, M. Scagliarini, L. Fuccio*
*Autore corrispondente per questo lavoro
  • Alma Mater Studiorum University of Bologna
  • Ospedale S. Maria delle Croci
  • IRCCS Istituto Europeo di Oncologia - Milano
  • IRCCS Istituto nazionale tumori Fondazione Giovanni Pascale - Napoli
  • Ospedale Valduce
  • Presidio Spedali Civili
  • IRCCS Azienda Unità Sanitaria Locale di Reggio Emilia
  • University of Bologna
  • IRCCS Istituto Clinico Humanitas - Rozzano (Milano)
  • Ospedale Nuovo Regina Margherita

Risultato della ricerca: Contributo in rivistaArticolo

Abstract

Background âPatients with prior colon cancer have increased risk of metachronous colorectal neoplasms; therefore, endoscopic surveillance is indicated. Current recommendations are not risk-stratified. We investigated predictive factors for colorectal neoplasms to build a model to spare colonoscopies for low-risk patients. Methods â This was a multicenter, retrospective study including patients who underwent surgery for colon cancer in 2001âŠ-âŠ2008 (derivation cohort) and 2009âŠ-âŠ2013 (validation cohort). A predictive model for neoplasm occurrence at second surveillance colonoscopy was developed and validated. Results â 421 and 203 patients were included in derivation and validation cohort, respectively. At second surveillance colonoscopy, 112 (26.6âŠ%) and 55 (27.1âŠ%) patients had metachronous neoplasms in derivation and validation groups; three cancers were detected in the latter. History of left-sided colon cancer (OR 1.64, 95âŠ%CI 1.02âŠ-âŠ2.64), ≥âŠ1 advanced adenoma at index colonoscopy (OR 1.90, 95âŠ%CI 1.05âŠ-âŠ3.43), and ≥âŠ1 adenoma at first surveillance colonoscopy (OR 2.06, 95âŠ%CI 1.29âŠ-âŠ3.27) were independently predictive of metachronous colorectal neoplasms at second surveillance colonoscopy. For patients without such risk factors, diagnostic accuracy parameters were: 89.3âŠ% (95âŠ%CI 82.0âŠ%-94.3âŠ%) and 78.2âŠ% (95âŠ%CI 65.0âŠ%-88.2âŠ%) sensitivity, and 28.5âŠ% (95âŠ%CI 23.5âŠ%-33.9âŠ%) and 33.8âŠ% (95âŠ%CI 26.2âŠ%-42.0âŠ%) specificity in derivation and validation group, respectively. No cancer would be missed. Conclusions â Patients with prior left-sided colon cancer or ≥âŠ1 advanced adenoma at index colonoscopy or ≥âŠ1 adenoma at first surveillance colonoscopy had a significantly higher risk of neoplasms at second surveillance colonoscopy; patients without such factors had much lower risk and could safely skip the second surveillance colonoscopy. A prospective, multicenter validation study is needed.
Lingua originaleInglese
pagine (da-a)220-226
Numero di pagine7
RivistaEndoscopy
Volume52
Numero di pubblicazione3
DOI
Stato di pubblicazionePubblicato - 2020

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

  1. SDG 3 - Salute e benessere
    SDG 3 Salute e benessere

All Science Journal Classification (ASJC) codes

  • Gastroenterologia

Keywords

  • metachronous neoplasms

Fingerprint

Entra nei temi di ricerca di 'How to identify patients who are less likely to have metachronous neoplasms after a colon cancer: A predictive model'. Insieme formano una fingerprint unica.

Cita questo